This website requires Javascript for some parts to function properly. Your experience may vary.

A quick guide to Carrier Screening and Non-Invasive Prenatal Testing for GPs | 4Cyte Pathology

4Cyte in partnership with Victorian Clinical Genetics Services: A quick guide to Carrier Screening and Non-Invasive Prenatal Testing for GPs

1 HOUR Educational Activity

Carrier Screening (CS) and Non-Invasive Prenatal Testing (NIPT) have transformed prenatal care by providing safer and more accurate methods of assessing the risk of genetic and chromosomal conditions in a pregnancy. These tests offer prospective parents valuable information that can support informed reproductive decision-making and pregnancy planning. This e-learning course provides GPs with essential genetics knowledge, enhancing their ability to provide high-quality antenatal care. By improving understanding and confidence in genomic testing, GPs can better manage pre- and post-test counselling, ultimately leading to more informed reproductive planning and improved patient outcomes.

Learning objectives

By the end of this activity, participants will be able to:

  1. Describe the difference between standard and expanded (small panel vs large panel) CS.
  2. Identify key elements of informed consent and post-test genetic counselling for CS.
  3. Interpret CS results and outline appropriate management strategies.
  4. Integrate CS into their practice efficiently and with a patient-focused approach.
  5. Discuss the accuracy and limitations of NIPT.
  6. Describe the difference between standard and genome-wide NIPT.
  7. Identify key elements of informed consent and post-test genetic counselling for NIPT.
  8. Interpret NIPT results and outline appropriate management strategies.

Course Information

Course Plan

  • Two Self-Paced Modules
  • Interactive Online Assessments: Embedded questions for engagement and knowledge checks throughout the modules.

To participate in this activity, please follow these steps

Your CPD Hours

Your CPD hours will be uploaded by 4Cyte within 4 weeks upon completion of the activity.